4.3 Review

Management of conjunctival melanoma

Journal

EXPERT REVIEW OF ANTICANCER THERAPY
Volume 9, Issue 9, Pages 1227-1239

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERA.09.85

Keywords

brachytherapy; conjunctiva; conjunctival melanocytic intra-epithelial neoplasia; cryotherapy; grading; melanoma; melanoma in situ; melanosis; mitomycin C; primary acquired melanosis; staging; treatment

Categories

Ask authors/readers for more resources

Invasive conjunctival melanoma can arise de novo, from nevus or from melanoma in situ. The literature reports that after treatment of invasive conjunctival melanoma more than 50% of patients develop local tumor recurrence, with 20% eventually requiring orbital exenteration and 20-30% developing fatal metastasis. Our results have improved since we replaced adjuvant cryotherapy with radiotherapy and topical chemotherapy. There is scope for multicenter clinical trials and translational research, but these require consistent staging and grading of disease. We propose that the term 'primary acquired melanosis' should only be used clinically, when the histology is not known. We have devised a clinical system for mapping conjunctival melanocytic lesions and a system for scoring the histological grade of atypia of conjunctival melanocytic intra-epithelial neoplasia/melanoma in situ. We anticipate that these measures will improve outcomes after treatment of conjunctival melanoma in situ and invasive melanoma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging

Ankit Singh Tomar, Paul T. Finger, Brenda Gallie, Tero Kivela, Ashwin Mallipatna, Chengyue Zhang, Junyang Zhao, Matthew Wilson, Rachel Brennan, Michala Burges, Jonathan Kim, Jesse L. Berry, Rima Jubran, Vikas Khetan, Suganeswari Ganeshan, Andrey Yarovoy, Vera Yarovaya, Elena Kotova, Denis Volodin, Yacoub Yousef, Kalle Nummi, Tatiana L. Ushakova, Olga Yugay, Vladimir G. Polyakov, Marco Antonio Ramirez-Ortiz, Elizabeth Esparza-Aguiar, Guillermo L. Chantada, Paula Schaiquevich, Adriana C. Fandino, Jason C. Yam, Winnie W. Lau, Carol P. Lam, Phillipa Sharwood, Sonia Moorthy, Quah Boon Long, Vera Adobea Essuman, Lorna A. Renner, Ekaterina Semenova, Jaume Catala-Mora, Maria Correa Llano, Elisa Carreras

Summary: This study analyzed data from 1054 RB eyes from 18 ophthalmic oncology centers worldwide and found that eyes with diffuse intraocular distribution of RB seeds had a higher risk of local treatment failure compared to eyes with focal seeds. Therefore, further subclassification of AJCC RB category cT2b into focal and diffuse seeds can improve prognostication for eye salvage.

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

Article Ophthalmology

Diagnostic uncertainty following orbital injury from a grease gun

Muhammed Jawad, Krishna Yamini, Ziyaad Sultan, Sarah Coupland, James Hsuan, Austin McCormick

Summary: This article presents a case of retained intraorbital grease, discussing the clinical and radiological findings, as well as the management approach.

ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY (2023)

Article Ophthalmology

Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study

Stine Dahl Vest, Sarah E. Coupland, Bita Esmaeli, Paul T. Finger, Gerardo F. Graue, Hans E. Grossniklaus, Tine Gadegaard Hindso, Frederik Holm, Santosh G. Honavar, Jwu Jin Khong, Marina Knudsen Kirkegaard, Penelope A. McKelvie, Lauge Hjorth Mikkelsen, Kaustubh Mulay, Peter Kristian Rasmussen, Volkert Siersma, Lene Dissing Sjo, Matthew C. Sniegowski, Bradley A. Thuro, Geeta K. Vemuganti, Steffen Heegaard

Summary: The specific location of ocular adnexal lymphoma (OAL) and the AJCC TNM tumour stage are prognostic factors for mortality in different OAL subtypes. Eyelid lymphoma has the highest disease-specific mortality in all subtypes.

BRITISH JOURNAL OF OPHTHALMOLOGY (2023)

Article Ophthalmology

Ruthenium106 plaque brachytherapy for uveal leiomyoma: a new approach to treatment?

Katharina Eibenberger, Rumana Hussain, Yamini Krishna, Sarah E. Coupland, Heinrich Heimann

Review Ophthalmology

Conjunctival Lymphoma

Lindsay A. McGrath, David A. Ryan, Sunil K. Warrier, Sarah E. Coupland, William J. Glasson

Summary: Conjunctival lymphoma is an ocular malignancy derived from clonal proliferation of lymphocytes. The majority of cases are extranodal marginal zone B-cell lymphoma, but other subtypes also exist. Clinical manifestations are nonspecific, but typically present as painless conjunctival lesions. Treatment approaches focus on local immunomodulation. Recent advancements in sequencing technologies have improved clinicians' ability to predict disease recurrence and systemic involvement.
Article Ophthalmology

Using the Chick Embryo Model to Examine the Effects of Hypoxia Pre-conditioning of Uveal Melanoma Cells on Tumor Growth and Metastasis

James Draper, Jodi Alexander, Rohini M. Nair, Nicole Scullion, Revu V. L. Narayana, Karen Aughton, Geeta K. Vemuganti, Helen Kalirai, Sarah E. Coupland

Summary: This study aimed to investigate the effects of hypoxia on tumor growth and dissemination in uveal melanoma (UM), and found that hypoxia pre-conditioning does not drive a metastatic phenotype in UM.

CURRENT EYE RESEARCH (2023)

Article Medicine, General & Internal

1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model

Kayleigh Slater, Rosa Bosch, Kaelin Francis Smith, Chowdhury Arif Jahangir, Sandra Garcia-Mulero, Arman Rahman, Fiona O'Connell, Josep M. Piulats, Valerie O'Neill, Noel Horgan, Sarah E. Coupland, Jacintha O'Sullivan, William M. Gallagher, Alberto Villanueva, Breandan N. Kennedy

Summary: A study found that high expression of CysLT(1) is associated with poor prognosis in primary uveal melanoma (UM). Additionally, quininib and 1,4-dihydroxy quininib drugs were able to alter cancer hallmarks of UM cell lines in vitro. The study also highlighted the diagnostic and therapeutic potential of CysLT(1) and ATP5F1B in UM.

FRONTIERS IN MEDICINE (2023)

Letter Ophthalmology

Retinoinvasive amelanotic ring melanoma of the ciliary body

Stephanie Lemaitre, Caroline Thaung, Sarah E. Coupland, Mandeep S. Sagoo

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2023)

Article Ophthalmology

Tumor-Associated Retinal Pigmentation in Choroidal Melanoma

Alexander Wallace, Yamini Krishna, Sarah E. Coupland, Heinrich Heimann, Asterios Diafas, Rumana N. Hussain

Summary: This study reports a previously unrecognized clinical feature of choroidal melanoma, termed tumor-associated retinal pigmentation (TARP), which represents tumor-associated macrophages. This feature is associated with choroidal melanomas of high metastatic-risk clinical and genetic characteristics.

OPHTHALMOLOGY (2023)

Article Oncology

Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma

Helena Robinson, Antonio Eleuteri, Joseph J. Sacco, Rumana Hussain, Heinrich Heimann, Azzam F. G. Taktak, Bertil Damato, Alexander J. Thompson, Thomas Allen, Helen Kalirai, Sarah E. Coupland

Summary: This study compares the accuracy of different prognostic systems for targeting surveillance programs in uveal melanoma patients. It suggests that the Liverpool Uveal Melanoma Prognosticator Online III (LUMPOIII) offers greater specificity and provides guidance for its use. This study provides valuable information for revising the clinical guidelines for surveillance in uveal melanoma.

CANCERS (2023)

Article Chemistry, Medicinal

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery

Jie Yin, Gangyin Zhao, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Gabriel Forn-Cuni, Annemijn P. A. Wierenga, Martine J. Jager, B. Ewa Snaar-Jagalska, Arwin Groenewoud

Summary: Given the rarity of uveal melanoma and the lack of effective treatments, researchers have developed a method to collect and preserve limited tissue samples from primary tumors and metastases for advanced research and drug screening.

PHARMACEUTICALS (2023)

Article Cell Biology

Patient-derived zebrafish xenografts of uveal melanoma reveal ferroptosis as a drug target

Arwin Groenewoud, Jie Yin, Maria Chiara Gelmi, Samar Alsafadi, Fariba Nemati, Didier Decaudin, Sergio Roman-Roman, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, Martine J. Jager, Felix B. Engel, B. E. Snaar-Jagalska

Summary: This study established a patient-derived animal model for metastatic UM and identified ferroptosis induction as a possible therapeutic strategy for the treatment of UM patients.

CELL DEATH DISCOVERY (2023)

Editorial Material Ophthalmology

The 5th edition of the World Health Organization Classification of Tumours of the Eye and Orbit

Tatyana Milman, Hans E. Grossniklaus, Gabrielle Goldman-Levy, Tero T. Kivela, Sarah E. Coupland, Valerie A. White, Hardeep Singh Mudhar, Charles G. Eberhart, Robert M. Verdijk, Steffen Heegaard, Anthony J. Gill, Martine J. Jager, Aberlardo A. Rodriguez-Reyes, Bita Esmaeli, Jennelle C. Hodge, Ian A. Cree

Summary: The 5th edition of the WHO Classification of Tumours of the Eye and Orbit is a significant step in standardizing diagnostic practices globally. It introduces new chapters and consolidates sections, highlighting recent advances in etiology, pathogenesis, and diagnosis of eye and orbital tumors. This edition also includes updates on classification schemes and newly identified tumors. The editorial summarizes the major changes and specific updates in each taxonomic category, focusing on advances in understanding tumor pathogenesis, diagnostic criteria, and molecular markers.

OCULAR ONCOLOGY AND PATHOLOGY (2023)

Review Oncology

Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities

Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, Carlos R. Figueiredo

Summary: Immune checkpoint therapies can enhance the function of anti-tumour T cells and improve outcomes in cancer patients. However, some patients are refractory to this therapy due to "cold" tumours that do not allow T cell generation or the infiltration of existing anti-tumour T cells. This review explores the mechanisms by which cancer cells induce T cell "desertification" and "exclusion" in these refractory tumours, and highlights the importance of developing immunotherapies that restore T cell generation and tumour trafficking.

BRITISH JOURNAL OF CANCER (2023)

Article Genetics & Heredity

SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

Philip Bland, Harry Saville, Patty T. Wai, Lucinda Curnow, Gareth Muirhead, Jadwiga Nieminuszczy, Nivedita Ravindran, Marie Beatrix John, Somaieh Hedayat, Holly E. Barker, James Wright, Lu Yu, Ioanna Mavrommati, Abigail Read, Barrie Peck, Mark Allen, Patrycja Gazinska, Helen N. Pemberton, Aditi Gulati, Sarah Nash, Farzana Noor, Naomi Guppy, Ioannis Roxanis, Guy Pratt, Ceri Oldreive, Tatjana Stankovic, Samantha Barlow, Helen Kalirai, Sarah E. Coupland, Ronan Broderick, Samar Alsafadi, Alexandre Houy, Marc-Henri Stern, Stephen Pettit, Jyoti S. Choudhary, Syed Haider, Wojciech Niedzwiedz, Christopher J. Lord, Rachael Natrajan

Summary: SF3B1 mutations confer sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPi). Mechanistically, this is independent of homologous recombination repair and instead relies on a defective replication stress response due to a reduction of the cyclin-dependent kinase 2 interacting protein (CINP). PARPi treatment of SF3B1 mutant (SF3B1(MUT)) tumors leads to replication stress induced by increased fork origin firing and culminates in cell cycle stalling. SF3B1 hotspot mutations are associated with a poor prognosis in several tumor types and lead to global disruption of canonical splicing.

NATURE GENETICS (2023)

No Data Available